Enter multiple symbols separated by commas

Johnson & Johnson


  • WASHINGTON, May 6- The U.S. Food and Drug Administration will hold a public meeting this summer to address drug company concern that restrictions on what they can say about off-label use of drugs violate their first amendment right to free speech. Efforts by drug companies to change the rules gained steam after a 2012 decision from the Second Circuit Court of...

  • INTERVIEW-New-look GSK bets on consumer health spending Wednesday, 6 May 2015 | 7:19 AM ET

    LONDON, May 6- Consumers from New York to New Delhi are digging deeper in their pockets for over-the-counter remedies and health products, a trend GlaxoSmithKline is banking on to help shape the next chapter in its evolution. In the biggest shake-up in its 15- year history, GSK has just sold its cancer drugs to Novartis, while buying the Swiss group's vaccine...

  • Dividend ETFs lose ground. Time to buy? Tuesday, 5 May 2015 | 2:10 PM ET
    Traders on the floor of the New York Stock Exchange.

    Why are dividend ETFs getting knocked as company after company raise their payouts?

  • Siemens unit in China bribery probe - report Sunday, 3 May 2015 | 5:42 AM ET
  • The investigation, which has not previously been reported, follows a wide-reaching probe into the pharmaceutical industry in China that last year saw GlaxoSmithKline Plc fined nearly $500 million for bribing officials to push its medicine sales. "We are not aware of any situation that conforms to what you describe," said Germany- based spokesman Matthias...

  • WASHINGTON, May 1- U.S. factory activity failed to gain steam in April after slowing for five straight months, but stronger-than-expected vehicle sales suggested the economy was finding some momentum after almost stalling in the first quarter. "The reacceleration in growth will not come fast enough for many, especially those looking for a liftoff by the Fed to...

  • WASHINGTON, May 1- The U.S. manufacturing expansion held steady at near a two-year low in April, but a jump in consumer sentiment and stronger-than-expected vehicle sales suggested the economy was pulling out of a first-quarter soft patch. The Institute for Supply Management said its index of national factory activity was at 51.5 in April, matching the March...

  • April 28- Boston Scientific Corp on Tuesday said it reached its first settlement agreement to resolve a portion of the legal claims it faces involving its transvaginal mesh product to treat urinary incontinence. The new agreement includes a case in the district court of Dallas County, Texas, for which there is a judgment of about $35 million that is subject to...

  • Dollar hits Pfizer; Merck 'blew away' estimates Tuesday, 28 Apr 2015 | 9:04 AM ET
    Tablets of Pfizer Inc.'s Lipitor and Merck & Co.'s Zocor.

    Pfizer reported a 4 percent drop in quarterly revenue, while Merck posted earnings that topped expectations.

  • Protests that forced companies to change Tuesday, 28 Apr 2015 | 8:25 AM ET
    Protester using megaphone during demonstration

    Using demonstrations and campaigns in traditional and social media, consumers are increasingly forcing companies to change their ways.

  • April 28- Medical device maker Boston Scientific Corp cut its full-year revenue and profit forecasts as it continues to bear the brunt of charges from a number of lawsuits. Boston Scientific said in February it would pay Johnson& Johnson $600 million to settle a long-running lawsuit over Boston Scientific's acquisition of rival Guidant in 2005..

  • April 28- U.S. drugmaker Pfizer Inc cut its full-year revenue and profit forecast, blaming a stronger dollar. Pfizer's shares were roughly unchanged at $34.62 in premarket trade on Tuesday morning. Pfizer's net profit rose to $2.38 billion, or 38 cents per share, in the latest quarter, from $2.33 billion, or 36 cents per share, a year earlier.

  • The 10 global companies that get diversity: Study Friday, 24 Apr 2015 | 11:03 AM ET

    These 10 companies lead the way when it comes to diversity as a cultural and business aim, according to an annual ranking from DiversityInc.

  • April 24- Advertising agency Interpublic Group of Cos Inc's quarterly revenue trumped expectations as higher ad spending by U.S. businesses made up for the strong dollar's impact on international revenue. Interpublic, whose clients include General Motors Co, Johnson& Johnson and L'Oréal, got about 60 percent of revenue from the United States in the first...

  • *Global nutraceutical market seen at $280 bln by 2018. LONDON, April 21- A boom in "nutraceuticals"- food and drinks with potential health benefits- is paving the way for a rush of deals, as food and drug companies compete to dominate a market expected to be worth $280 billion by 2018.. "The space is ripe for M&A and I think you are going to see more," added Jeremy Johnson,...

  • LONDON, April 16- Shares in French drugmaker Ipsen and its Swedish partner Active Biotech fell sharply on Thursday after the companies announced an experimental medicine had failed to extend lives for prostate cancer sufferers. Ipsen stock was down 10 percent in early trade while Active Biotech, which originally developed the drug, slumped 60 percent.

  • US industrial output falls on mining, utilities Wednesday, 15 Apr 2015 | 12:18 PM ET
    A worker welds an aluminum case at the Aluminum Case Company in Chicago.

    Industrial production recorded its biggest drop in more than 2-1/2 years, fresh evidence that economic growth slowed sharply in the first quarter.

  • WRAPUP 1-Mining, utilities sink U.S. industrial production Wednesday, 15 Apr 2015 | 11:05 AM ET

    WASHINGTON, April 15- U.S. industrial output posted its biggest drop in more than 2-1/ 2 years in March in part as oil and gas well drilling plummeted, highlighting the negative impact of lower crude prices and a strong dollar on the economy. An unusually snowy winter weighed on activity early in 2015. Labor disruptions at normally busy West Coast ports, as well as...

  • Cramer Remix: This company's worth double Tuesday, 14 Apr 2015 | 7:33 PM ET
    Jim Cramer on the set of Mad Money

    “Mad Money” host Jim Cramer’s revealing an undervalued play that may surprise you.

  • UPDATE 1-Aduro IPO pricing values drugmaker at $1 bln Tuesday, 14 Apr 2015 | 6:23 PM ET

    Aduro, which counts Johnson& Johnson and Swiss drugmaker Novartis AG among its investors, is selling all the 7 million shares in the offering. To gain access to Aduro's cancer immunotherapy technology, Novartis last month entered into a tie-up worth about $750 million with the company. Novartis Institutes for BioMedical Research Inc, an affiliate of Novartis,...